NZM2:ETR
Novozymes
55,72 €
arrow_upward
+0,22%(+0,12) 1 D
2. okt., 17:30:00 GMT+2 · EUR
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for NZM2 …
Åpne
55,00 €
Høy
55,74 €
Lav
55,00 €
Markedsverdi
171,20 mrd.
Snittvolum
161,00
Volum
360,00
52 u høy
61,96 €
52 u lav
46,74 €
Antall ansatte
11k
Åpne
55,00 €
Høy
55,74 €
Lav
55,00 €
Markedsverdi
171,20 mrd.
Snittvolum
161,00
Volum
360,00
52 u høy
61,96 €
52 u lav
46,74 €
Antall ansatte
11k
Nyhetssaker
Fra nettkilder og nyhetspartnere
Dairy Business Middle East & Africa
·
for 1 time siden
Novonesis strengthens dairy innovation with facility expansion
AD HOC NEWS
·
for 2 timer siden
Novonesis completes MicroBioGen acquisition: Novonesis stock trades EUR 55.72
Profil
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, outside of Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
Om Novozymes
Administrerende direktørEster Baiget
Ansatte11,1k
Grunnlagt2000
Hovedkontor-
SektorSpeciality chemicals
Nettstednovonesis.com